Surveillance report
Evidence
Review and download supporting evidence. Includes the full guideline if available.
Supporting evidence
-
-
2024 exceptional surveillance of intrapartum care (NICE guideline NG235)
-
-
-
Appendix A: Equality and health inequalities assessment template (PDF 194 KB)
-
-
Appendix A: Stakeholder consultation comments table (PDF 792 KB)
-
2019 surveillance of intrapartum care for healthy women and babies (NICE guideline CG190)
-
Appendix A: Summary of evidence from surveillance (PDF 1020 KB)
-
Appendix B: Stakeholder consultation comments table (PDF 1.35 MB)
-
Other supporting evidence
-
-
-
-
-
-
-
Evidence review
-
-
B: Initial assessment of women reporting prelabour rupture of membranes (PDF 671 KB)
-
-
-
-
F: Use of oxytocin in the first or second stage of labour (PDF 877 KB)
-
-
-
-
J: Prophylactic antibiotics for birth with forceps or ventouse (PDF 744 KB)
-
K: Active and physiological management of the third stage (PDF 921 KB)
-
L: Route of administration of oxytocin in the third stage of labour (PDF 1.02 MB)
-
M: Uterotonics for the prevention of postpartum haemorrhage (PDF 4.93 MB)
-
-
O: Pharmacological management of postpartum haemorrhage (PDF 2.16 MB)
-
-
Full guidance
-
-
-
-